COMPANY PROFILE

Lantheus Holdings

Explore full profile

Lantheus Medical Imaging, a global leader in developing, manufacturing, selling

Bedford, United StatesFounded 1956Health Tech & Medtech

Valuation $6.53B Market cap · 2026

Revenue $1.50B Latest reported FY

EBITDA $543M Latest reported FY

About Lantheus Holdings

Lantheus is a leading company specializing in innovative diagnostics, targeted therapeutics, and artificial intelligence (AI) solutions designed to empower clinicians in the healthcare sector. Operating primarily in the medical diagnostics and therapeutics market, Lantheus serves healthcare providers, including hospitals, clinics, and specialized medical practitioners. The company’s business model revolves around the development, manufacturing, and commercialization of pioneering diagnostic and therapeutic products, as well as AI-driven solutions that enhance disease detection, treatment, and monitoring. Revenue is generated through the sale of these advanced medical products and solutions, which are integral to improving patient outcomes and healthcare efficiency. Lantheus has a strong focus on innovation, leveraging its extensive experience and expertise to continuously expand its product pipeline and strengthen its diagnostic capabilities. The company’s commitment to better patient outcomes is evident in its collaborative culture and dedication to scientific advancement.

MoreLess Source: Dealroom company data

At a glance

Status: Listed
Founded: 1956
Headquarters: Bedford, United States
Listing: IPO 2015
Employees: 876
Open positions: 49
Dealroom signal: 61.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Oncology, Radioisotope Therapeutics, Radiopharmaceuticals
Technology: Big Data, Deep Tech, Computer Vision
Business model: Manufacturing
Client focus: b2b
Investment activity: 7 companies, latest Jan 2025
Capital deployed: $87M
Preferred round: ACQUISITION
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Aug 2026	$8B	$8B	Curium Pharma	↗
IPO✓Exit	Jun 2015	$0	—	Undisclosed	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin	Profit	Margin	R&D
2026	$1.5B	-2.8%	$543M	36.2%	$320M	21.3%	$177M
2025	$1.5B	+0.5%	$409M	26.5%	$234M	15.2%	$177M
2024	$1.5B	+18.3%	$551M	35.9%	$312M	20.4%	$168M
2023	$1.3B	+38.6%	$444M	34.3%			$78M
2022	$935M	+119.9%	$34M	3.7%
2021	$425M	+25.3%	−$83M	-19.6%
2020	$339M	—	−$2M	-0.6%

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Lantheus Holdings website traffic

Latest recorded traffic for Lantheus Holdings is 7.3K monthly website visits, down 13.1% over the last three months. Lantheus Holdings's team grew 0% over the past year.

Latest monthly visits7.3K 3-month web change-13.1% 1-year team growth0%

Monthly website visitsDec 2018–Mar 2021

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Key Account Manager-Nuc MedAlbuquerque, New Mexico, United States, Northern America, Americas · Sales · Oct 4, 2026 Senior Specialist (Manager), Order Management Systems and ProcessesBedford, Massachusetts, United States, Northern America, Americas · Other · Sep 25, 2026 Key Account Manager - Nuclear MedicineIndianapolis, Indiana, United States, Northern America, Americas · Sales · Sep 25, 2026 Key Account Manager- Cardiology in Omaha/IowaOmaha, Nebraska, United States, Northern America, Americas · Other · Sep 25, 2026 Senior Specialist (Manager), Order Management Systems and ProcessesGreater Boston · Other · Sep 24, 2026 Key Account Manager-Neurology201, Burlington Road, Bedford, Middlesex County, Massachusetts, 01730, United States · Sales · Sep 22, 2026 Executive Director, Head of Clinical Development - OncologyBedford, Massachusetts, United States, Northern America, Americas · Other · Sep 15, 2026 Clinical Research, Senior Principal Scientist (Director), OncologyBedford, Massachusetts, United States, Northern America, Americas · Other · Sep 15, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
STSHINE TechnologiesDeploying and scaling near-term applications of fusion technology that we hope will one day lead to powering the world	Janesville, United States	Operational	370	$1.1B	$1.2B
NMNorthstar Nuclear MedicineProviding patients global access to game-changing radiopharmaceuticals	Madison, United States	Operational
CPClarity PharmaceuticalsPersonalized medicine company focused on the treatment of serious disease	Sydney, Australia	Operational
TAThor Medical ASPowering the future of cancer treatment through sustainable alpha-emitter innovation	Oslo, Norway	Acquired
IIIsotope InnovationsProvider of safe, pure isotopes to the medical community, which provides physicians with the tools they need to keep people healthy.	—	Operational
ATAriceum TherapeuticsTargeted radiopharmaceuticals for hard-to-treat cancers	Berlin, Germany	Operational
FTFull-Life TechnologiesRadionuclide therapeutics platform targeting alpha-emitter isotope delivery	Gembloux, Belgium	Operational
RARatiotxSpecializing in the development of targeted radiotherapeutics for the treatment of cancer	Boston, United States	Operational